Joint Venture is a community of innovators, entrepreneurs, researchers, investors and others interested in driving innovation and entrepreneurship within musculoskeletal (MSK) health, hosted by Orthopaedic Research UK.

Joint Venture provides:

  • A forum for debate with regular on and off-line meetings
  • A force for positive change, especially in tackling systemic barriers to innovation
  • Access for early-stage MSK start-ups to potential investment, mentoring, education and networking support
  • A dynamic and supportive network

The aim of Joint Venture is to encourage innovation and entrepreneurialism within musculoskeletal health in the UK. This means:

more

MSK researchers aspiring to commercialise their work
MSK companies being able to scale their businesses in the UK
MSK spinouts from our universities
Innovative MSK companies bringing products and services to market

Our next event

Joint Venture is a forum for debate, with regular on and off-line meetings plus training events.

Event
Navigating the regulatory landscape – a notified body perspective.
Online
Date & Time
30 June 2026, 2:00pm
View all

What you get from being part of Joint Venture

Investment

The opportunity to pitch for ORUK funding, plus access to angels, VCs, and other investors.

Read more

Academy

Developing entrepreneurial skills

Read more

Networking

Building valuable connections through regular face-to-face events and webinars.

Joint Venture has been a great way to get to know a whole community of MSK innovators in the UK. There’s a great mix of people, experience and skills and we have learned lots about UK innovation, how people do it and where we can make it better.

Professor Andy Metcalfe, Chief Medical Officer, Founder & Director, VerIQ

It is encouraging to see organisations like Joint Venture actively driving conversations, collaboration and practical change to better support innovators, researchers and patients.

Iva Hauptmannova, Director, Research Untangled

Equity support from ORUK has been very valuable to a young company like Renovos, because ORUK support, in addition to vital cash, provides external validation from a well-respected, specialist organisation as well as access to new contacts and networks.

James Otter, Chairman, Renovos

Joint Venture highlights a range of highly relevant topic and has been a great forum for advancing business development activities.

Joe Dupere, Chief Executive Officer, VerIQ

Championing innovation and entrepreneurship in MSK health in the UK

8
start ups funded by ORUK
189
active innovative MSK companies in UK
£580m
equity funding raised by innovative MSK companies (2015-25)
43
innovative MSK spinouts

Latest News

Royal Academy of Engineering launches accelerator

If you’re leading a high-growth deep tech or engineering SME and preparing to scale, this programme from the…

Read more

ORUK launches MSK start-up fund

ORUK has announced the launch of this year’s Ronald Furlong Fund for UK-registered MSK health startups. Named in…

Read more

ORUK forms investment committee

March saw the first meeting of our Investment Sub Committee, which is responsible for monitoring ORUK’s growing portfolio…

Read more

Partners


Join the Joint Venture network

Membership of Joint Venture is open to innovators, entrepreneurs, researchers, investors and others interested in driving innovation and entrepreneurship within musculoskeletal health. Membership is free and allows access to exclusive resources, plus advance notice of funding opportunities and events.

Join today

Joint Venture is hosted by Orthopaedic Research UK (ORUK) which is one of most significant funders of MSK research and innovation in the UK.

Learn more >